EXHIBIT 99.1 • Net revenue of $375.3 million • Organic revenue increased 0.6% • GAAP net loss of $20.1 million • Adjusted EBITDA of $40.6 million • Cash provided by operating activities of $42.3 million, free cash flow of $15.5 million • Global Points of Access ("POA") decreased 960, or 6.1%, to 14,851 reflecting the strategic closure of unprofitable POA 1. Refranchising: Improve financial flexibility through refranchising international markets and restructuring the joint venture in the Western U.S. 2. Impr ...

Exhibit 99.1 ALTICE USA REPORTS THIRD QUARTER 2025 RESULTS NEW YORK (November 6, 2025) -- Altice USA (NYSE: ATUS) today reports results for the third quarter ended September 30, 2025. Dennis Mathew, Altice USA Chairman and Chief Executive Officer, said: "In the third quarter, we delivered record gross margin performance and improved operational efficiencies, reaffirmed our full-year Adjusted EBITDA outlook, continued to elevate our customer and network experience, and achieved a milestone of over 700 thousa ...

Exhibit 99.1 FOR IMMEDIATE RELEASE MasterCraft Boat Holdings, Inc. Reports Fiscal 2026 First Quarter Results VONORE, Tenn. – November 6, 2025 – MasterCraft Boat Holdings, Inc. (NASDAQ: MCFT) today announced financial results for its fiscal 2026 first quarter ended September 28, 2025. The overview, commentary, and results provided herein relate to our continuing operations, which consists of our MasterCraft and Pontoon segments. Overview: Brad Nelson, Chief Executive Officer, commented, "We delivered results ...

Exhibit 99.1 Lantheus Reports Third Quarter 2025 Financial Results and Provides Business Update BEDFORD, Mass., November 6, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (Lantheus or the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today reported financial results for its third quarter ended September 30, 2025. "Lantheus' third quarter results underscore the strength of our s ...

Exhibit 99.1 Silence Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights SANRECO Phase 2 study of divesiran in polycythemia vera (PV) fully enrolled; topline results anticipated in 3Q 2026 Strong balance sheet and cash runway into 2028 6 November 2025 • Completed enrollment in the SANRECO Phase 2 study of divesiran for the treatment of PV. The Phase 2 portion of SANRECO is a global, randomized, double-blind, placebo-controlled trial that enrolled 48 phlebotomy-dependent ...

EXHIBIT 99.1 REGENXBIO Reports Third Quarter 2025 Financial Results and Operational Highlights ROCKVILLE, Md., November 6, 2025 (PR Newswire) -- REGENXBIO Inc. (Nasdaq: RGNX) today reported financial results and operational highlights for the third quarter ended September 30, 2025. "The positive data and significant clinical milestones achieved across each of our late-stage programs underscore the meaningful progress we're making towards delivering potentially transformative gene therapies," said Curran M. ...

Revenue Performance - Revenue for the three months ended September 30, 2025, decreased by $720,000, or 44.8%, to $887,000 from $1.6 million in the same period of 2024, primarily due to a decline in service revenue from technology and services contracts [160]. - One customer accounted for 89% of total revenue for the three months ended September 30, 2025, compared to one customer accounting for 54% and another for 32% in the same period of 2024 [161]. - Revenue decreased by $0.1 million, or 3.5%, to $3.6 million for the nine months ended September 30, 2025, largely due to reduced service revenue from government and commercial contracts [170]. Operating Loss and Expenses - Operating loss for the three months ended September 30, 2025, was $19.9 million, compared to a loss of $13.9 million in the same period of 2024 [158]. - Selling, general and administrative expenses rose to $10 million for the three months ended September 30, 2025, compared to $8 million in the same period of 2024, driven by business growth and public company compliance costs [158]. - Research and development expenses increased to $5.2 million for the three months ended September 30, 2025, from $3.5 million in the same period of 2024, reflecting ongoing investment in PNT technologies [158]. - Selling, general and administrative expenses increased by $6.2 million, or 25.2%, to $30.8 million for the nine months ended September 30, 2025, primarily due to higher payroll-related and stock-based compensation expenses [174]. - Research and development expenses for the nine months ended September 30, 2025, increased by $1.7 million, or 13.7%, to $14.0 million, mainly due to higher non-recurring engineering services [173]. Cash Flow and Financing Activities - Net cash used in operating activities for the nine months ended September 30, 2025 was $34.7 million, compared to $26.1 million for the same period in 2024 [182][184]. - Net cash used in investing activities during the nine months ended September 30, 2025 was $35.0 million, up from $17.7 million in 2024 [185][186]. - Net cash provided by financing activities for the nine months ended September 30, 2025 was $120.1 million, significantly higher than $29.7 million in 2024 [187][188]. - The company entered into a Note Purchase Agreement to sell $190.0 million in 5% Senior Secured Convertible Notes due in 2028 [181]. - Cash proceeds from the issuance of the 2028 Notes were a primary contributor to the financing activities in 2025 [187]. Patents and Regulatory Changes - The company has been granted 165 patents related to its systems and services, enhancing its competitive position in the PNT market [141]. - The company signed an agreement to acquire an additional 4 MHz of M-LMS licenses, expanding its spectrum coverage to over 90% of the U.S. population [142]. - The company is pursuing regulatory changes to the Lower 900 MHz band to enable a 15 MHz nationwide spectrum configuration for both PNT and 5G broadband services [143]. Other Financial Metrics - Other income increased significantly to $23.6 million for the three months ended September 30, 2025, compared to $2.5 million in the prior year, primarily due to gains from changes in fair value of derivative liabilities [169]. - The company incurred net losses of $121.3 million for the nine months ended September 30, 2025, compared to $69.6 million in the prior year, with cash and cash equivalents totaling $167.6 million as of September 30, 2025 [179]. - The company reported a net loss of $121.3 million for the nine months ended September 30, 2025, compared to a net loss of $69.6 million in 2024 [183][184]. - Non-cash charges included $36.4 million for change in the fair value of derivative liability and $12.5 million for stock-based compensation in 2025 [183]. - The company experienced a net increase in operating liabilities of $5.7 million during the nine months ended September 30, 2025 [183]. Depreciation and Cost of Goods Sold - Cost of Goods Sold (COGS) decreased by $0.5 million, or 21.0%, to $2.0 million for the three months ended September 30, 2025, primarily due to reductions in payroll-related expenses and software license costs [162]. - COGS for the nine months ended September 30, 2025, decreased by $1.7 million, or 20.1%, to $6.6 million, driven by lower payroll-related and software license expenses [171]. - Depreciation and amortization expenses surged by $2.2 million, or 170.1%, to $3.5 million for the three months ended September 30, 2025, attributed to accelerated depreciation of retired network assets [166]. Market Risks - There were no material changes in market risks from those disclosed in the 2024 Form 10-K [191].

EXHIBIT 99 November 6, 2025 Cummins Reports Strong Third Quarter Operating Results, Records Non-Cash Charges Related to its Electrolyzer Business COLUMBUS, IND. - Cummins Inc. (NYSE: CMI) today reported results for the third quarter of 2025. "Cummins delivered strong operating results in the third quarter, driven by profitable growth in our Power Systems and Distribution segments, due in part to continued rising demand for backup power for datacenters. Effective cost management across the company helped nav ...

Portfolio Composition - As of September 30, 2025, the gross book value of the company's portfolio was comprised of 41% multi-family, 40% office, 11% hotels, 6% life science, and 2% mixed use and other[190]. - The top market by gross book value is Manhattan, accounting for 21% of the total, followed by Washington, DC at 10% and Boston at 8%[219]. - The portfolio is diversified with 41% in multifamily properties and 40% in office properties, indicating a balanced investment strategy[220]. Financial Performance - Total revenues for the three months ended September 30, 2025, were $96.2 million, an increase of $5.5 million compared to $90.7 million for the same period in 2024[226]. - For the nine months ended September 30, 2025, total revenues increased to $287.7 million from $273.8 million for the same period in 2024, representing a growth of 5.1%[242]. - Net income for the nine months ended September 30, 2025, was $86.7 million, compared to $80.5 million in 2024, marking an increase of 7.6%[242]. - Interest income from sales-type leases rose to $72.4 million for the three months ended September 30, 2025, up from $67.1 million in the same period in 2024, driven by new originations[228]. - Interest income from sales-type leases rose to $212.7 million for the nine months ended September 30, 2025, up from $195.6 million in 2024, an increase of 8.8%[242]. - Earnings from equity method investments decreased to $14.6 million for the nine months ended September 30, 2025, down from $18.1 million in 2024, a decline of 19.4%[254]. Expenses and Losses - General and administrative expenses for the three months ended September 30, 2025, were $13.1 million, slightly down from $13.1 million in the same period in 2024[235]. - The provision for credit losses for the nine months ended September 30, 2025, was $5.7 million, a decrease from $8.4 million in the same period of 2024, reflecting improved market conditions[252]. - Interest expense increased to $154.2 million for the nine months ended September 30, 2025, compared to $147.7 million in 2024, an increase of 4.0% due to higher indebtedness[247]. Liquidity and Capital Management - The company has a liquidity capacity of $1.1 billion under its 2024 Unsecured Revolver as of September 30, 2025, enhancing its financial flexibility[264]. - The company entered into a new $2.0 billion unsecured revolving credit facility in April 2024, replacing previous facilities and extending maturity to May 1, 2029[262]. - As of September 30, 2025, the company had $12.1 million of unrestricted cash and $1.1 billion of undrawn capacity on its 2024 Unsecured Revolver[266]. - The company expects to meet its liquidity requirements over the next 12 months through cash on hand, cash flows from operations, and unused borrowing capacity[267]. Investment Strategy - The company targets Ground Lease investments where the initial cost represents 30% to 45% of the Combined Property Value, indicating a strong correlation between inflation and commercial real estate values over time[198]. - The company identifies a significant market opportunity in the approximately $7.0 trillion institutional commercial property market in the U.S., aiming to expand the use of Ground Leases beyond current fragmented ownership[210]. - The company has initiated new products such as the Ground Lease Plus Fund and Leasehold Loan Fund to enhance its service offerings and capture more market share[211]. Risk Factors - The company has entered into a forbearance agreement with a tenant under a significant New York office asset, which poses risks of potential losses if the tenant defaults[194]. - The rise in interest rates has adversely affected the U.S. office sector, leading to increased vacancies and reduced market liquidity, which could negatively impact the company's tenants and property values[192]. - A 100 basis point increase in interest rates could result in a decrease in net income by approximately $3.994 million[280]. - The company aims to mitigate interest rate volatility through hedging instruments, including interest rate swap agreements[277]. Cash Flow Analysis - Cash flows provided by operating activities increased to $35.495 million for the nine months ended September 30, 2025, compared to $29.957 million in 2024[268]. - Cash flows used in investing activities decreased to $(180.185) million in 2025 from $(190.897) million in 2024, primarily due to a decrease in the origination of Ground Leases[268]. - Cash flows provided by financing activities increased to $148.831 million in 2025 from $138.462 million in 2024, driven by acquisition activities in 2024[268]. Shareholder Actions - The company authorized a share repurchase program of up to $50.0 million on February 4, 2025, allowing for strategic capital management[259]. - As of September 30, 2025, approximately 14.4% of the outstanding Caret units were beneficially owned by the company's officers and employees, with 128,971 Caret units remaining available for issuance under the Caret Performance Incentive Plan[208].

Exhibit 99.1 Conference Call Information NextNav will host a conference call for analysts and investors at 9:00 am ET on Thursday, November 6, 2025. Registration for the conference call can be completed by visiting the following website prior to, or on the day of, the conference call: https://registrations.events/direct/Q4I6293644. After registering, each participant will be provided with call details and a registrant ID. Reminders will also be sent to registered participants via email. Alternatively, the c ...